---
figid: PMC4760278__koni-05-01-1065370-g002
figlink: /pmc/articles/PMC4760278/figure/f0002/
number: F2
caption: Sinergistic effects of PARP inhibitors and mAbs targeting EGF, HER2 and VEGF
  pathways. (A) Ligands binding to EGFR activates various intracellular signaling
  pathways including AKT, ERK and STAT pathways resulting in increased cell proliferation,
  migration, survival and expression of components of the HR pathway. HER2 activation
  requires heterodimerization with other (ligand-bound) EGFR-family receptors, most
  notably HER3 (left panel). These processes are limitated by mAbs targeting these
  receptors (central panel). Interestingly, decrease HR components expression may
  generate a BRCAness situation that in the presence of PARP inhibitors result in
  synthetic lethality and cell death. Moreover, PARP inhibitors might overcame the
  resistance to mAbs targeting either EGFR or HER2 by different mechanisms (right
  panel). (B) Ligand binding to VEGF activates various intracellular signaling pathways
  including AKT, and ERK resulting in angiogenesis. mAbs against VEGF or VEGFR prevent
  the activation of VEGF-dependent signaling pathways and therefore limited angiogenesis.
  Mechanisms of resistance to mAbs targeting VEGF pathway comprise the activation
  of a hypoxia response including HIF induction, which in turn drives the release
  of additional angiogenic factors. PARP inhibitors dampen the expression and function
  of HIF. In addition, cells exposed to hypoxia have decreseased HR response that
  in the presence of PARP inhibitors might leads to cell death by the principle of
  synthetic lethality.
pmcid: PMC4760278
papertitle: Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors.
reftext: José Yélamos, et al. Oncoimmunology. 2016;5(1):e1065370.
pmc_ranked_result_index: '47592'
pathway_score: 0.890957
filename: koni-05-01-1065370-g002.jpg
figtitle: Sinergistic effects of PARP inhibitors and mAbs targeting EGF, HER2 and
  VEGF pathways
year: '2016'
organisms: Homo sapiens
ndex: db76dede-df11-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4760278__koni-05-01-1065370-g002.html
  '@type': Dataset
  description: Sinergistic effects of PARP inhibitors and mAbs targeting EGF, HER2
    and VEGF pathways. (A) Ligands binding to EGFR activates various intracellular
    signaling pathways including AKT, ERK and STAT pathways resulting in increased
    cell proliferation, migration, survival and expression of components of the HR
    pathway. HER2 activation requires heterodimerization with other (ligand-bound)
    EGFR-family receptors, most notably HER3 (left panel). These processes are limitated
    by mAbs targeting these receptors (central panel). Interestingly, decrease HR
    components expression may generate a BRCAness situation that in the presence of
    PARP inhibitors result in synthetic lethality and cell death. Moreover, PARP inhibitors
    might overcame the resistance to mAbs targeting either EGFR or HER2 by different
    mechanisms (right panel). (B) Ligand binding to VEGF activates various intracellular
    signaling pathways including AKT, and ERK resulting in angiogenesis. mAbs against
    VEGF or VEGFR prevent the activation of VEGF-dependent signaling pathways and
    therefore limited angiogenesis. Mechanisms of resistance to mAbs targeting VEGF
    pathway comprise the activation of a hypoxia response including HIF induction,
    which in turn drives the release of additional angiogenic factors. PARP inhibitors
    dampen the expression and function of HIF. In addition, cells exposed to hypoxia
    have decreseased HR response that in the presence of PARP inhibitors might leads
    to cell death by the principle of synthetic lethality.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF5
  - FGF23
  - EGFR
  - MAPK3
  - AKT2
  - MAPK1
  - ERBB2
  - FGF6
  - FGF4
  - FGF22
  - FGF18
  - FGF17
  - FGF7
  - AKT1
  - TIPARP
  - PARP14
  - AKT3
  - FGF16
  - PARP12
  - PARP8
  - TNKS2
  - FGF20
  - PARP15
  - FGF3
  - STAT4
  - STAT5A
  - STAT5B
  - STAT6
  - FGF8
  - FGF9
  - PARP9
  - PARP10
  - FGF19
  - FGF14
  - FGF1
  - FGF2
  - PGF
  - VEGFA
  - VEGFB
  - VEGFC
  - EPAS1
  - HIF1A
  - HIF3A
  - FGF10
  - FGF11
  - FGF12
  - FGF21
  - THRB
  - VEGFD
  - PDGFA
  - PDGFB
  - FLT4
  - PARP16
  - PARP11
  - FLT1
  - FGF13
  - KDR
  - STAT1
  - STAT2
  - PARP6
  - PDGFD
  - PDGFC
  - PARP4
  - PARP2
  - TNKS
  - THRA
  - PARP1
  - STAT3
  - PARP3
  - Cancer
genes:
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: THR
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRB
  entrez: '7068'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: THR
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRA
  entrez: '7067'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4760278__F2
redirect_from: /figures/PMC4760278__F2
figtype: Figure
---
